Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein

Journal of Hepatology

Volumn 37, Issue 6, 2002, Pages 855-862

  Schüttler, Christian G ^a   Fiedler, Nicola ^a   Schmidt, Katja ^a   Repp, Reinald ^b   Gerlich, Wolfram H ^a   Schaefer, Stephan ^a,c  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Coinfection; Hepatitis B virus basic core promoter; Hepatitis C virus core protein; Hepatitis C virus genotype; trans Repression

Indexed keywords

CORE PROTEIN; TRANSCRIPTION FACTOR; PEPTIDE FRAGMENT;

ANIMAL CELL; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA BINDING; ENHANCER REGION; EXPRESSION VECTOR; GENETIC TRANSFECTION; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER CELL CULTURE; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SUPERINFECTION; TRANSCRIPTION REGULATION; VIRUS INFECTION; VIRUS INHIBITION; VIRUS REPLICATION; ANIMAL; CELL CULTURE; CELL LINE; CHEMISTRY; DRUG EFFECT; GENETICS; LIVER CELL; METABOLISM;

ANIMALS; CELL LINE; ENHANCER ELEMENTS (GENETICS); GENOTYPE; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; MICE; PEPTIDE FRAGMENTS; TUMOR CELLS, CULTURED; VIRAL CORE PROTEINS;

EID: 0036893160     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(02)00296-9     Document Type: Article

References (46)

1. World Health Organization. WHO Infectious Diseases Report, 1999. In http://www.who.int/infectious-disease-report/index-rpt99.html. WHO; 1999.
2. Pontisso P, Gerotto M, Benvegnu L, Chemello L, Alberti A. Coinfection by hepatitis B virus and hepatitis C virus. Antivir Ther 1998;3:137-142.
3. Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998;75(347):354.
4. Lai MM, Ware CF. Hepatitis C virus core protein: Possible roles in viral pathogenesis. Curr Top Microbiol Immunol 2000;242:117-134.
5. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999;341:22-26.
6. Bradley DW, Maynard JE, McCaustland KA, Murphy BL, Cook EH, Ebert JW. Non-A, non-B hepatitis in chimpanzees: Interference with acute hepatitis A virus and chronic hepatitis B virus infections. J Med Virol 1983;11:207-213.
7. Brotman B, Prince AM, Huima T, Richardson L, van den Ende MC, Pfeifer U. Interference between non-A, non-B and hepatitis B virus infection in chimpanzees. J Med Virol 1983;11:191-205.
8. Sagnelli E, Coppola N, Scolastico C, Filippini P, Santantonio T, Stroffolini T, Piccinino F. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis. Hepatology 2000;32:1106-1110.
9. Jardi R, Rodriguez F, Buti M, Costa X, Cotrina M, Galimany R, et al. Role of hepatitis B, C, and D viruses in dual and triple infection: Influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 2001;34:404-410.
10. Fukuda R, Ishimura N, Niigaki M, Hamamoto S, Satoh S, Tanaka S, et al. Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: Clinical and virological significance. J Med Virol 1999;58:201-207.
11. Berger A, Doerr HW, Rabenau HF, Weber B. High frequency of HCV infection in individuals with isolated antibody to hepatitis B core antigen. Intervirology 2000;43:71-76.
12. Sagnelli E, Coppola N, Scolastico C, Mogavero AR, Filippini P, Piccinino F, CV genotype and 'silent' HBV coinfection: Two main risk factors for a more severe liver disease. J Med Virol 2001;64:350-355.
13. Shih CM, Lo SJ, Miyamura T, Chen SY, Lee YH. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol 1993;67:5823-5832.
14. Shih CM, Chen CM, Chen SY, Lee YH. Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation. J Virol 1995;69:1160-1171.
15. Kosovsky MJ, Qadri I, Siddiqui A. The regulation of hepatitis B virus gene expression: An overview of the cis- and trans-acting components. In: Koshy R, Caselmann W, editors. Hepatitis B Virus: Molecular Mechanisms in Disease and Novel Strategies for Therapy, London: Imperial College Press, 1998. pp. 21-50.
16. Uchida T, Shimojima M, Gotoh K, Shikata T, Tanaka E, Kiyosawa K. 'Silent' hepatitis B virus mutants are responsible for non-A, non-B, non-C, non-D, non-E hepatitis. Microbiol Immunol 1994;38:281-285.
17. Bock CT, Malek NP, Tillmann HL, Manns MP, Trautwein C. The enhancer I core region contributes to the replication level of hepatitis B virus in vivo and in vitro. J Virol 2000;74:2193-2202.
18. Wu JC, Merlino G, Cveklova K, Mosinger Jr B, Fausto N. Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1. Cancer Res 1994;54:5964-5973.
19. Aden DP, Fogel A, Plotkin S, Damjanov I, Knowles BB. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 1979;282:615-616.
20. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. Current Protocols in Molecular Biology, New York: Wiley, 1998.
21. Lo SY, Selby M, Tong M, Ou JH. Comparative studies of the core gene products of two different hepatitis C virus isolates: Two alternative forms determined by a single amino acid substitution. Virology 1994;199:124-131.
22. Lu W, Strohecker A, Ou JH. Post-translational modification of the hepatitis C virus core protein by tissue transglutaminase. J Biol Chem 2001;276:47993-47999.
23. Zein NN. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 2000;13:223-235.
24. Günther S, Fiscber L, Pult I, Sterneck M, Will H. Naturally occurring variants of hepatitis B virus. Adv Virus Res 1999;52(25):137.
25. Günther S, Piwon N, Iwanska A, Schilling R, Meisel H, Will H. Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease. J Virol 1996;70:8318-8331.
26. Hope RG, McLauchlan J. Sequence motifs required for lipid droplet association and protein stability are unique to the hepatitis C virus core protein. J Gen Virol 2000;81:1913-1925.
27. Hope RG, Murphy DJ, McLauchlan J. The domains required to direct core proteins of hepatitis C virus and GB virus-B to lipid droplets share common features with plant oleosin proteins. J Biol Chem 2002;277:4261-4270.
28. Ray RB, Ghosh AK, Meyer K, Ray R. Functional analysis of a trans-repressor domain in the hepatitis C virus core protein. Virus Res 1999;59:211-217.
29. Bergqvist A, Rice CM. Transcriptional activation of the interleukin-2 promoter by hepatitis C virus core protein. J Virol 2001;75:772-781.
30. Kabe Y, Goto M, Shima D, Imai T, Wada T, Morohashi K, et al. The role of human MBFI as a transcriptional coactivator. J Biol Chem 1999;274:34196-34202.
31. Ko L, Cardona GR, Henrion-Caude A, Chin WW. Identification and characterization of a tissue-specific coactivator, GTI98, that interacts with the DNA-binding domains of nuclear receptors. Mol Cell Biol 2002;22:357-369.
32. Li D, Wang F, Samuels HH, Domain structure of the NRIF3 family of coregulators suggests potential dual roles in transcriptional regulation. Mol Cell Biol 2001;21:8371-8384.
33. Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I, et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev 2000;14:2819-2830.
34. Lou DQ, Tannour M, Selig L, Thomas D, Kahn A, Vasseur-Cognet M. Chicken ovalbumin upstream promoter-transcription factor II, a new partner of the glucose response element of the L-type pyruvate kinase gene, acts as an inhibitor of the glucose response. J Biol Chem 1999;274:28385-28394.
35. Ishizuka T, Satoh T, Monden T, Shibusawa N, Hashida T, Yamada M, Mori M. Human immunodeficiency virus type 1 Tat binding protein-1 is a transcriptional coactivator specific for TR. Mol Endocrinol 2001;15:1329-1343.
36. Jin DY, Wang HL, Zhou Y, Chun AC, Kibler KV, Hou YD, et al. Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation. EMBO J 2000; 19:729-740.
37. Yasui K, Wakita T, Tsukiyama-Kohara K, Funahashi SI, Ichikawa M, Kajita T, et al. The native form and maturation process of hepatitis C virus core protein. J Virol 1998;72:6048-6055.
38. Suzuki R, Suzuki T, Ishii K, Matsuura Y, Miyamura T. Processing and functions of hepatitis C virus proteins. Intervirology 1999;42:145-152.
39. Ray RB, Ray R. Hepatitis C virus core protein: Intriguing properties and functional relevance. FEMS Microbiol Lett 2001;202:149-156.
40. Kann M, Gerlich WH. In: Mahy BWJ, Collier L, editors. 9th ed. Topley and Wilson's Microbiology and Microbial Infections, vol. 1. London: Arnold, 1998. pp. 745-773.
41. Xie Y, Li M, Wang Y, Hofschneider PH, Weiss L. Site-specific mutation of the hepatitis B virus enhancer II B1 element: Effect on virus transcription and replication. J Gen Virol 2001;82:531-535.
42. Lai CK, Ting LP. Transcriptional repression of human hepatitis B virus genes by a bZIP family member, E4BP4. J Virol 1999;73:3197-3209.
43. Gilbert S, Galarneau L, Lamontagne A, Roy S, Belanger L. The hepatitis B virus core promoter is strongly activated by the liver nuclear receptor fetoprotein transcription factor or by ectopically expressed steroidogenic factor 1. J Virol 2000;74:5032-5039.
44. Ishida H, Ueda K, Ohkawa K, Kanazawa Y, Hosui A, Nakanishi F, et al. Identification of multiple transcription factors, HLF, FTF, and E4BP4, controlling hepatitis B virus enhancer II. J Virol 2000;74:1241-1251.
45. Sun CT, Lo WY, Wang IH, Lo YH, Shiou SR, Lai CK, Ting LP. Transcription repression of human hepatitis B virus genes by negative regulatory element-binding protein/SON. J Biol Chem 2001;276:24059-24067.
46. Nakanishi-Matsui M, Hayashi Y, Kitamura Y, Koike K. Integrated hepatitis B virus DNA preserves the binding sequence of transcription factor Yin and Yang 1 at the virus-cell junction. J Virol 2000;74:5562-5568.